Product Recall

The recall is due to a malfunction risk that could, if not handled properly, cause the pump to stop working for a long period of time. This could lead to a serious injury or death, according to the recall. 

If researchers can find ways to prevent AKI after TAVR, it could help decrease the risk of poor outcomes in more ways than one. 

Cardiovascular information systems (CVIS) combine imaging and reporting into one system that allows access across the cardiovascular service line. Here are 7 trends in CVIS according to KLAS.

Monique Rasband, vice president of imaging, cardiology and oncology, KLAS Research, explains a few of the key technology trends in cardiovascular information systems (CVIS).

FDA recall. The medications involved are atenolol, which treats hypertension, and the antiplatelet agent clopidogrel, which reduces the risk of an acute myocardial infarction (AMI) or stroke among patients with a history of AMI, severe chest pain or circulation problems.

Patients face a risk of adverse events if they mistakenly take the wrong medication, according to a new warning from the FDA. 

Innovation at work

Updates about transcatheter aortic valve replacement (TAVR) are always big news, but the new five-year data from the CoreValve™ US Pivotal and SURTAVI trials came as a welcome surprise to many cardiologists. 

Sponsored by Medtronic

Around the web

More than 120 medical societies have joined the AMA in a letter urging congressional leaders to enact long-term solutions to the systemic problems in the Medicare physician payment system and to address cuts that are going into effect in 2023.

This image gallery shows what the various clinical presentations associated with the COVID-19 virus that have been documented during the coronavirus pandemic.